BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21503571)

  • 21. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck.
    Farmer RW; Richtsmeier WJ; Scher RL
    Head Neck; 1998 Dec; 20(8):726-31. PubMed ID: 9790295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.
    de Koning PJ; Bovenschen N; Leusink FK; Broekhuizen R; Quadir R; van Gemert JT; Hordijk GJ; Chang WS; van der Tweel I; Tilanus MG; Kummer JA
    Int J Cancer; 2009 Oct; 125(7):1542-50. PubMed ID: 19569240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells.
    Young MR; Wright MA; Lozano Y; Prechel MM; Benefield J; Leonetti JP; Collins SL; Petruzzelli GJ
    Int J Cancer; 1997 Feb; 74(1):69-74. PubMed ID: 9036872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
    Noorlag R; van der Groep P; Leusink FK; van Hooff SR; Frank MH; Willems SM; van Es RJ
    Head Neck; 2015 Aug; 37(8):1130-6. PubMed ID: 24764155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood-borne metastasis via an invasion-independent pathway.
    Sugino T; Yamaguchi T; Ogura G; Kusakabe T; Goodison S; Homma Y; Suzuki T
    J Pathol; 2007 Jun; 212(2):152-60. PubMed ID: 17455170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma.
    Wang X; Jin Y; Li YX; Yang Y
    Oncol Rep; 2018 Apr; 39(4):1793-1804. PubMed ID: 29436667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.
    Ge L; Smail M; Meng W; Shyr Y; Ye F; Fan KH; Li X; Zhou HM; Bhowmick NA
    PLoS One; 2011; 6(11):e27529. PubMed ID: 22096589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells.
    Choi BD; Jeong SJ; Wang G; Park JJ; Lim DS; Kim BH; Cho YI; Kim CS; Jeong MJ
    Int J Mol Med; 2011 Oct; 28(4):527-34. PubMed ID: 21687932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of fibroblast growth factor binding protein in head and neck cancer.
    Li W; Wang C; Juhn SK; Ondrey FG; Lin J
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):896-901. PubMed ID: 19770422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
    Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
    Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.